Cutaneous T cell lymphoma

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search
Cutaneous T cell lymphoma
Classification and external resources
ICD-10 C84.0, C84.1
ICD-9 202.1, 202.2
ICD-O: M9700/3, M9701/3
DiseasesDB 8595
eMedicine med/3486 
MeSH D016410

WikiDoc Resources for

Cutaneous T cell lymphoma

Articles

Most recent articles on Cutaneous T cell lymphoma

Most cited articles on Cutaneous T cell lymphoma

Review articles on Cutaneous T cell lymphoma

Articles on Cutaneous T cell lymphoma in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Cutaneous T cell lymphoma

Images of Cutaneous T cell lymphoma

Photos of Cutaneous T cell lymphoma

Podcasts & MP3s on Cutaneous T cell lymphoma

Videos on Cutaneous T cell lymphoma

Evidence Based Medicine

Cochrane Collaboration on Cutaneous T cell lymphoma

Bandolier on Cutaneous T cell lymphoma

TRIP on Cutaneous T cell lymphoma

Clinical Trials

Ongoing Trials on Cutaneous T cell lymphoma at Clinical Trials.gov

Trial results on Cutaneous T cell lymphoma

Clinical Trials on Cutaneous T cell lymphoma at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Cutaneous T cell lymphoma

NICE Guidance on Cutaneous T cell lymphoma

NHS PRODIGY Guidance

FDA on Cutaneous T cell lymphoma

CDC on Cutaneous T cell lymphoma

Books

Books on Cutaneous T cell lymphoma

News

Cutaneous T cell lymphoma in the news

Be alerted to news on Cutaneous T cell lymphoma

News trends on Cutaneous T cell lymphoma

Commentary

Blogs on Cutaneous T cell lymphoma

Definitions

Definitions of Cutaneous T cell lymphoma

Patient Resources / Community

Patient resources on Cutaneous T cell lymphoma

Discussion groups on Cutaneous T cell lymphoma

Patient Handouts on Cutaneous T cell lymphoma

Directions to Hospitals Treating Cutaneous T cell lymphoma

Risk calculators and risk factors for Cutaneous T cell lymphoma

Healthcare Provider Resources

Symptoms of Cutaneous T cell lymphoma

Causes & Risk Factors for Cutaneous T cell lymphoma

Diagnostic studies for Cutaneous T cell lymphoma

Treatment of Cutaneous T cell lymphoma

Continuing Medical Education (CME)

CME Programs on Cutaneous T cell lymphoma

International

Cutaneous T cell lymphoma en Espanol

Cutaneous T cell lymphoma en Francais

Businness

Cutaneous T cell lymphoma in the Marketplace

Patents on Cutaneous T cell lymphoma

Experimental / Informatics

List of terms related to Cutaneous T cell lymphoma

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Cutaneous T-Cell lymphoma (CTCL) is a class of non-Hodgkin's lymphoma, which is a type of cancer of the immune system. Unlike most non-Hodgkin's lymphomas (which are generally B-cell related), CTCL is caused by a mutation of T cells. The malignant T cells in the body are pushed to the surface of the skin in a biological process used to rid the body of offending material, causing various lesions to appear on the skin. These lesions change shape as the disease progresses, typically beginning as what appears to be a rash and eventually forming plaques and tumors before metastatizing to other parts of the body.

Types

Though there are many types of CTCL and presentation can vary from individual to individual, there are two main forms:

There is some dispute over whether SS is an advanced form of MF or a different type of CTCL entirely - in either case, the prognosis for SS patients is substantially poorer than for those of MF.

Treatment

There is no cure for CTCL, but there are a variety of treatment options available and some CTCL patients are able to live somewhat normal lives with this cancer, although symptoms can be debilitating and painful, even in earlier stages.

Treatments include: Topical Corticosteroids, Bexarotene Gel, Carmustine(Nitrogen Mustard), Mechlorethamine, Phototherapy (Broad & Narrow Band UVB or PUVA), Local & Total Skin Electron Beam Radiation, Conventional Radiation Therapy, Oral Corticosteroids, Bexarotene (Targretin®) Capsules, Photopheresis, Interferons, Denileukin Diftitox (Ontak®), Alemtuzumab (Campath-1H), Vorinostat (Zolinza®), Methotrexate, Pentostatin & other purine analogues (Fludarabine, 2- deoxychloroadenosine), Liposomal doxorubicin (Doxil®), Gemcitabine (Gemzar®), Cyclophosphamide, oral, Bone marrow/Stem cell, and Allogenic Transplantation.

See also

External links

WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch


Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

Personal tools